Subcutaneous versus intravenous formulation of trastuzumab for HER2-positive early breast cancer: updated results from the phase III HannaH study.
| Image |  |
|---|---|
| Description | scientific article published on 17 November 2014 |
| Author/s |
author: Daniil Stroyakovskiy Xavier Pivot |
| Publication date | November 17, 2014 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |